Projects per year
Organization profile
Organisation profile
Graduate Institute of Pharmacognosy was established in1992. The first chairman was professor Yen Kun-Ying. Through 22 sessions, Institute has been educating over 197 Masters.
The research of Graduate Institute of Pharmacognosy cultivates outstanding professionals for industry, research and professional practice. Our research focuses on isolation and structural chemistry of medical herbs, and the development of Chinese herbs and functional foods for anti-hypertension, anti-hepatitis, anti-hyperglycemia, anti-cancer, and immune regulation. By the cooperation with government and biotechnology industry, pharmacognosy development can fit up with people’s need and government’s policy. In education, the core value is applying pharmacognosy, crude drugs development, and clinical research on Chinese herbal medicine. Students are instructed the ability to research chemical substances and reactivity of Chinese herbal medicine as well as skills for isolating and analyzing the structures of natural products, natural products pharmacology, molecular mechanisms and knowledge associated with applying Chinese herbal medicine to clinical medical needs. After graduation, students seek careers associated with Chinese herbal medicine or biotechnology.
Fingerprint Dive into the research topics where Graduate Institute of Pharmacognosy is active. These topic labels come from the works of this organisation's members. Together they form a unique fingerprint.
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Profiles
Projects
類薑黃素誘導人類大腸癌細胞株計畫性死亡探討
3/1/20 → 2/28/21
Project: C - Project of Alliance › s - Shin Kong Wu Ho-Su Memorial Hospital
利用內生性報告基因轉殖鼠以開發第一型糖尿病之治療藥物及其應用策略
1/1/20 → 12/31/20
Project: A - Government Institution › a - National Health Research Institutes
Development of an Innovative Bispecific Engager Simultaneously Binding Pd-L1 and Cd28 to Reverse Immunosuppressive Tumor Microenvironment for Enhancing Anti-Cancer Efficacy of T Cell-Based Therapies
8/1/19 → 7/31/20
Project: A - Government Institution › b - Ministry of Science and Technology
Research Output
Acetylcholinesterase inhibitory activity and neuroprotection: In vitro, molecular docking, and improved learning and memory functions of demethylcurcumin in scopolamine-induced amnesia ICR mice
Liu, Y. H., Lee, C. J., Chen, L. C., Lee, T. L., Hsieh, Y. Y., Han, C. H., Yang, C. H., Huang, W. J. & Hou, W. C., Mar 2020, In : Food and Function. 11, 3, p. 2328-2338 11 p.Research output: Contribution to journal › Article
1
Citation
(Scopus)
Correction to: Anti-glycation, anti-hemolysis, and ORAC activities of demethylcurcumin and tetrahydroxycurcumin in vitro and reductions of oxidative stress in d-galactose-induced BALB/c mice in vivo (Botanical Studies, (2019), 60, 1, (9), 10.1186/s40529-019-0258-x)
Liu, Y. H., Lee, T. L., Han, C. H., Lee, Y. S. & Hou, W. C., Dec 1 2020, In : Botanical Studies. 61, 1, 7.Research output: Contribution to journal › Comment/debate
Open Access
Corrigendum to“Isoindoline scaffold-based dual inhibitors of HDAC6 and HSP90 suppressing the growth of lung cancer in vitro and in vivo”[Eur. J. Med. Chem. 190 (2020 Mar 15) 112086] (European Journal of Medicinal Chemistry (2020) 190, (S0223523420300532), (10.1016/j.ejmech.2020.112086))
Ojha, R., Nepali, K., Chen, C. H., Chuang, K. H., Wu, T. Y., Lin, T. E., Hsu, K. C., Chao, M. W., Lai, M. J., Lin, M. H., Huang, H. L., Chang, C. D., Pan, S. L., Chen, M. C. & Liou, J. P., Sep 1 2020, In : European Journal of Medicinal Chemistry. 201, 112404.Research output: Contribution to journal › Comment/debate